Over the 20 years Dr. Joel Schlessinger has practiced dermatology, he has always tried to contribute to the scientific as well as medical field of dermatology.  Here is a listing of the many articles he has written.  He hopes to continue his work with writing as it gives him great pleasure to see others learning from his research and articles:

Bibliography of Joel Schlessinger, M.D.

Schlessinger, M.D., Joel.  Mole Removal.  Emedicine.com. April 29, 2001.

Schlessinger, M.D., Joel.  Jumpstarting Treatment.  Skin and Aging.  October 2003;11:92-96.

Schlessinger, M.D., Joel.  How to Evaluate New Cosmetic Technologies and Procedures.  Practical Dermatology.  May 2004;1(5):25-28.

Schlessinger, M.D., Joel.  Can Aesthetician Help You Grow Your Cosmetics Practice?  Practical Dermatology.  June 2004;1(6):30-34.

Schlessinger, M.D., Joel.  Retailing 101:  Understanding the Basics of Office Dispensing.  Practical Dermatology.  January 2005;2(1):55-57.

Schlessinger, M.D., Joel.  Retailing 102:  Tips to Fine-tune In Office Sales.  Practical Dermatology.  February 2005;2(2):29-32.

Schlessinger, M.D., Joel. Get the Most Benefit from AFA Peels for Facial Rejuvenation. Practical Dermatology, March 2005:14-15.

Schlessinger, M.D., Joel.  Starting a Medical Day Spa.  Cosmetic Dermatology.  April 2005;18(4):301-304.

Schlessinger, M.D., Joel.  Starting a Cosmetic Practice and Maintaining it!  September 2005;18(9):649-651.

Schlessinger, M.D., Joel.  Human Bites.  Emedicine.com. September 22, 2005.

Schlessinger, M.D., Joel.  Animal Bites.  Emedicine.com. September 28, 2005.

Schlessinger, M.D., Joel. Get Male Patients Through the Door; How to Market Cosmetic Products and Procedures. Practical Dermatology, February 2006:19-22.

Schlessinger, M.D., Joel. Building a Referral Base. Cosmetic Dermatology, July 2006:464-466.

Schlessinger J, Miller B, Gilbert RD, Plott RT; Vanos Study Group. An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis. Arch Dermatol. Dec 2006;142(12):1568-1572.

Schlessinger J, Menter A, Gold M, Leonardi C, Eichenfield L, Plott RT, Leyden J, Wortzman M; ZIANA Study Group. Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. J Drugs Dermatol. Jun 2007;6(6):607-615.

Elewski BE, Abramovits W, Kempers S, Schlessinger J, Rosen T, Gupta AK, Abraham S, Rowell R. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. J Drugs Dermatol. Oct 2007;6(10):1001-1008.

Schlessinger, M.D., Joel. Skin care for men and its marketing. Dermatol Ther. Nov-Dec 2007;20(6):452-456.

Schlessinger, M.D., Joel. Botulinums on the Horizon. Skin & Aging, February 2008:48-50.

Schlessinger, M.D., Joel. State of Cosmetic Dermatology, 2008. Cosmetic Dermatology, February 2008:67-68.

Del Rosso JQ, Schlessinger J, Werschler P. Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea. J Drugs Dermatol. June 2008;7(6):573-576.

Schlessinger, M.D., Joel. Spa dermatology: past, present, and future. Dermatol Clin. July 2008;26(3):403-411.

Schlessinger, M.D., Joel. Inappropriate Treatments by Inappropriate Practitioners. Cosmetic Dermatology. Sep 2008:483-484.

Kimball AB, Gold MH, Zib B, Davis MW; Clobetasol Propionate Emulsion Formulation Foam Phase III Clinical Study Group.* Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol. 2008 Sep;59(3):448-54, 454.el. Epub 2008 Jun 9.

Schlessinger, M.D., Joel. Ask an Expert: Do you rehire ex-employees if they are intent to return? Practical Dermatology. December 2008.

Schlessinger, M.D., Joel. Ask an Expert: How is the economic downturn affecting the medical side of practice? Practical Dermatology. January 2009.

Schlessinger, M.D., Joel. Ask an Expert: How can a cosmetic practice improve follow-through for procedures? Practical Dermatology. February 2009.

Schlessinger, M.D., Joel. Ask an Expert: Do you use e-mail in your practice. If so, how do you integrate it? Practical Dermatology. March 2009.

Schlessinger, M.D., Joel. When Does Value Pricing Become Simply Cheap? Cosmetic Dermatology. April 2009:173-174.

Schlessinger, M.D., Joel. Cosmetic Dermatology: Ensuring Success at Any Level. Practical Dermatology. April 2009.

Schlessinger, M.D., Joel. Ask an Expert: What methods do you use to track referral sources? Practical Dermatology. April 2009.

Rubin MG, Dover J, Glogau RG, Goldberg DJ, Goldman MP, Schlessinger J. The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment. J Drugs Dermatol. May 2009;8(5):439-444.

Schlessinger, M.D., Joel. Ask an Expert: What benefits do you provide for your employees or recommend that others offer? Practical Dermatology. May 2009.

Schlessinger, M.D., Joel. Ask an Expert: What forms of incentives do you give to spa employees or estheticians? Practical Dermatology. August 2009.

Gold LS, Tan J, Cruz-Santana A, Papp K, Poulin Y, Schlessinger J, Gidner J, Liu Y, Graeber M; Adapalene-BPO Study Group. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Cutis. Aug 2009;84(2):110-6.

Schlessinger, M.D., Joel. Beyond the Science: Botulinum Toxins in the Practice Setting. Practical Dermatology. October 2009.

Cohen JL, Schlessinger J, Cox SE, Lin X; Reloxin Investigational Group. An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar lines. Aesthet Surg J. Nov 2009;29(6 suppl):S43-9.

Schlessinger, M.D., Joel. Ask an Expert: Background Checks: Worth the Cost. Practical Dermatology. January 2010.

Fleischer AB Jr, Shalita A, Eichenfield LF, Abramovits W, Lucky A, Garrett S; Dapsone Gel in Combination Treatment Group.* Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study. J Drugs Dermatol. Jan 2010;9(1):33-40.

Schlessinger, M.D., Joel. Ask an Expert: Checks and Balances: More on Staff Hiring and Management. Practical Dermatology. February 2010.

Schlessinger, M.D., Joel. Ask an Expert: Thoughts on Collecting Payments…and Trimming the Fat. Practical Dermatology. March 2010.

Schlessinger, M.D., Joel. Ask an Expert: On Seeing and Hearing in a Dermatology Clinic. Practical Dermatology. April 2010.

Schlessinger, M.D., Joel. Ask an Expert: Navigating Complex and Changing Insurance Issues. Practical Dermatology. May 2010.

Eichenfield l, Jarratt M, Schlessinger J, Kempers S, Manna V, Hwa J, Liu Y, Graeber M.  Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies. J Drugs Dermatol. June 2010;9(6):639-646.

Schlessinger, M.D., Joel. Ask an Expert: Boosting Cosmeceutical Product Sales in the Office. Practical Dermatology. July 2010.

Schlessinger, M.D., Joel. Botulinum Toxins: Getting Acquainted. Practical Dermatology. August 2010.

Schlessinger, M.D., Joel. Addressing Patient Concerns About Sunscreen Safety. Practical Dermatology. October 2011.

Schlessinger, Joel, Schlessinger, Daniel, Schlessinger, Bernard.  Prospective Demographic Study of Cosmetic Surgery Patients. J Clin Aesthet Dermatol. November 2010;3(10):30-5.

Schlessinger, M.D., Joel. Ask an Expert: Tips For Starting Your Practice Website. Practical Dermatology. January 2011.

Schlessinger, M.D., Joel. Strategies for Successful Facial Rejuvenation. Practical Dermatology. February 2011.

Schlessinger, M.D., Joel. Paying for Search Engine Result Listings. Practical Dermatology. February 2011.

Schlessinger, M.D., Joel. Ask an Expert: On Touch-Ups and Follow-Ups. Practical Dermatology. April 2011.

Schlessinger, M.D., Joel. In-Office Dispensing: Expert Insight. Practical Dermatology. May 2011.

Schlessinger, M.D., Joel. Ask an Expert: Tips For Handling Employee Resignation. Practical Dermatology. May 2011.

Jewell ML, Baxter RA, Cox SE, Donofrio LM, Dover JS, Glogau RG, Kane MA, Weiss RA, Martin P, Schlessinger J. Randomized sham-controlled trial to evaluate the safety and effectiveness of a high-intensity focused ultrasound device for noninvasive body sculpting. Plast Reconstr Surg. July 2011;128(1):253-62.

Schlessinger, M.D., Joel, Kenkel J, Werschler P. Further Enhancement of Facial Appearance With a Hydroquinone Skin Care System Plus Tretinoin in Patients Previously Treated With Botulinum Toxin Type A.  Aesthet Surg J. July 2011;31(5):529-539.

Schlessinger, M.D., Joel, Monheit G, Kane MA, Mendelsohn N. Time to onset of Response of Abobotulinumtoxin A in the Treatment of Glabellar Lines: A Subset analysis of Phase 3 Clinical Trials of a New Botulinum Toxin Type A.  Dermatol Surgl. October 2011;37(10):1434-1442 [Published on-line. July 11, 2011|001:10.1111/j.1524-4725.2011.02075.x]

Tan M.D., Jerry; Gold M.D., Linda Stein; Schlessinger M.D., Joel; Brodell M.D., Robert; Jones M.D., Terry; Cruz, Alma; Kerrouche MSc, Nabil; Jarratt M.D., Michael.  Short-Term Combination Therapy and Long-Term Relapse Prevention in the Treatment of Severe Acne Vulgaris.  Journal of Drugs in Dermatology. February 2012. 11(2):174-180.

Schlessinger, M.D. Joel. Make the Most of Cosmeceutical Agents in Your Practice. Practical Dermatology. March 2012:48-51.

Schlessinger, M.D. Joel. New Frontiers in Neurotoxins. Practical Dermatology. May 2012:22-25.

Schlessinger, M.D. Joel. Fillers: Tips and Tools for Beginning and Honing Your Practice. Practical Dermatology. June 2012:25-27.

Schlessinger, M.D. Joel. Corey Maas, MD, FACS; Michael A. C. Kane, MD; Vivian W. Bucay, MD, FAAD; Consensus Committee: Shawn Allen, MD; David J. Applebaum, MD; Leslie Baumann, MD; Sue Ellen Cox, MD; Julius W. Few, MD; John H. Joseph, MD; Z. Paul Lorenc, MD, FACS; Amir Moradi, MD; Mark S. Nestor, MD, PhD; Technology Consultants: Mitchell Wortzman, PhD; Ira Lawrence, MD; Xiaoming Lin, RN, MS; and Diane Nelson, RN, MPH. Current Aesthetic Use of AbobotulinumtoxinA in Clinical Practice: An Evidence-Based Consensus Review. Aesthetic Surgery Journal. September 2012: 8S – 29S.

Schlessinger, M.D. Joel. Steven R. Weiss, MD; Mark Jewell, MD, PC; Vic Narurkar, MD; Susan Weinkle, MD; Michael H. Gold, MD; Erica Bazerkanian, MBA. Perceptions and Practices in Submental Fat Treatment: A Survey of Physicians and Patients. SkinMed Journal. January/February 2013: 27 – 31.

*Dr. Schlessinger was a member of the study group